Risk factors for Type 2 Diabetes Mellitus in Chronic Hepatitis C Virus-Infected Patients: A Retrospective Cohort Study in Southern China

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Chronic hepatitis C (CHC) is associated with an increased risk of type 2 diabetes mellitus (T2DM). However, regional variations in HCV genotypes and clinical characteristics may influence this association. This study aimed to investigate the association between chronic Hepatitis C virus (CHC) infection and the development of T2DM of CHC patients in southern China. Methods A retrospective cohort study analyzed 442 CHC patients (242 non-diabetic, 200 diabetic) from 2010–2018. Biochemical parameters, HCV genotypes, and clinical characteristics were compared. Multivariate logistic regression and ROC analysis were performed to evaluate predictors of T2DM. Results The CHC + DM group exhibited significantly higher age, BMI, fasting blood glucose, fasting insulin, HOMA-IR(Homeostasis Model Assessment-Insulin Resistance) index, transaminases alanine transaminase (ALT) and aspartate transaminase (AST), total bilirubin, γ-Glutamyl Transferase (GGT), and cirrhosis prevalence (all P < 0.05). Logistic regression analysis showed that age (OR: 1.09), fasting blood glucose (OR: 16.20), fasting insulin (OR: 1.23), HOMA-IR (OR: 0.48), and GGT (OR: 1.01), cirrhosis (OR: 15.32) and hypertension (OR: 31.00) were the risk factors of DM in CHC patients. HCV genotype 3a was more prevalent in T2DM patients ( P  = 0.008). Receiver Operating Characteristic curve analysis highlighted fasting glucose (AUC = 0.904) as the strongest predictor. Conclusion Age, metabolic dysregulation, liver cirrhosis, hypertension, and HCV genotype 3a are key risk factors for T2DM in CHC patients. Early screening for glucose intolerance and genotype-specific interventions are critical in high-risk populations.

Article activity feed